The Scientist

» biotechnology

Most Recent

image: Taking Shots at Ebola

Taking Shots at Ebola

By | November 5, 2014

With an infusion of public and private resources and accelerated regulatory processes, a handful of companies are racing to develop a vaccine to curb the Ebola epidemic.

4 Comments

image: Nurse Infected with Ebola in Spain

Nurse Infected with Ebola in Spain

By | October 6, 2014

The case marks the first person to contract the virus outside of West Africa.

0 Comments

image: The Second Coming of RNAi

The Second Coming of RNAi

By | September 1, 2014

Now showing clinical progress against liver diseases, the gene-silencing technique begins to fulfill some of its promises.

1 Comment

image: A Matter of Size

A Matter of Size

By | August 1, 2014

Erroneous characterization of nanomaterials can misinform the study of a new medicine’s safety and efficacy.

0 Comments

image: Nanomedicine

Nanomedicine

By , and | August 1, 2014

From bioimaging to drug delivery and therapeutics, nanotechnology is poised to change the way doctors practice medicine.

10 Comments

image: FDA Approves Prosthetic Arm

FDA Approves Prosthetic Arm

By | May 14, 2014

The agency OKs the first prosthetic arm controlled by neural signals from the user’s muscles.

0 Comments

image: The Promise of Nanomedicine

The Promise of Nanomedicine

By | April 8, 2014

At AACR, scientists discuss the growing interest in nanotechnology and how it can be used to study, diagnose, and treat cancer.

0 Comments

image: DARPA Puts Biotech at the Fore

DARPA Puts Biotech at the Fore

By | April 4, 2014

The U.S. Department of Defense is solidifying its focus on the life sciences with a new division of biotechnology.  

0 Comments

image: Biotech Superstar Dies

Biotech Superstar Dies

By | March 7, 2014

Alejandro Zaffaroni, who launched companies that developed birth control pills, microarrays, and transdermal drug patches, has died at age 91.  

0 Comments

image: Opinion: Translational Biotechnology

Opinion: Translational Biotechnology

By | February 17, 2014

Regulators must consider both the promise and potential pitfalls of new technologies when determining whether to move them into clinical trials.

0 Comments

Popular Now

  1. NYU Halts Studies, Suspends Investigator
    The Nutshell NYU Halts Studies, Suspends Investigator

    Experiments conducted at the New York University School of Medicine violated several research standards, according to US Food and Drug Administration investigators.

  2. The Meaning of Pupil Dilation
    Daily News The Meaning of Pupil Dilation

    Scientists are using pupil measurements to study a wide range of psychological processes and to get a glimpse into the mind.

  3. Exercise-Induced Muscle Factor Promotes Memory
  4. Zika and Dengue Immunity: A Complex Relationship